Work

Development and characterization of a first-in-class adjustable-dose gene therapy system

Year: 2024

Type: article

Source: Gene

DOI: 10.1016/j.gene.2024.148500

Authors: Alex Goraltchouk, Jared Lourie, Judith M. Hollander, H. Grace Rosen, Atsutaro A. Fujishiro, Francesco Luppino, Kai Zou, Alexey Seregin

Institution: University of Massachusetts Boston

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Science Foundation, University of Massachusetts Boston, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology, Targeting Dynamin-related protein 1-mediated mitochondrial fission to correct insulin resistance in obesity

OpenAlex ID: W4395117491

FWCI: 0.271

Cites: 87

Cited by: 2

Related to: 10